Crizanlizumab Disease Interactions
There is 1 disease interaction with crizanlizumab.
Moderate
Crizanlizumab (applies to crizanlizumab) hepatic/renal
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction, Liver Disease
The effect of renal or hepatic impairment on the pharmacokinetics of crizanlizumab is unknown. Caution is advised if used on these patients.
References (1)
- (2019) "Product Information. Adakveo (crizanlizumab)." Novartis Pharmaceuticals
Switch to consumer interaction data
Crizanlizumab drug interactions
There are 5 drug interactions with crizanlizumab.
Report options
QR code containing a link to this page
More about crizanlizumab
- crizanlizumab consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous uncategorized agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
